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Summary
The gastrointestinal tract carries out the complex
process of localizing the polymicrobial popula-
tions of the indigenous microbiota to the lumenal
side of the GI mucosa while absorbing nutrients
from the lumen and preventing damage to the
mucosa. This process is accomplished through a
combination of physical, innate and adaptive host
defences and a ‘strategic alliance’ with members of
the microbiota. To cope with the constant expo-
sure to a diverse microbial community, the GI tract,
through the actions of a number of specialized
cells in the epithelium and lamina propria, has
layers of humoral, physical and cellular defences
that limit attachment, invasion and dissemination
of the indigenous microbiota. However, the role of
the microbiota in this dynamic balance is vital and
serves as another level of ‘innate’ defence. We
are just beginning to understand how bacterial
metabolites aid in the control of potential patho-
gens within the microbiota and limit inflammatory
responses to the microbiota, concepts that will
impact our understanding of the biological effects
of antibiotics, diet and probiotics on mucosal
inflammatory responses.
Introduction
The gastrointestinal (GI) tract carries out the complex
process of localizing the polymicrobial microbiota to the
lumenal side of the GI mucosa while absorbing nutrients
from the lumen and preventing damage to the mucosa.
This process is accomplished through a combination of
physical, innate and adaptive host defences, and a part-
nership with members of the microbiota. The GI mucosa is
continuously exposed to ingested antigens and there are
an estimated 1014 indigenous bacteria that are also in
constant contact with the mucosa. The GI microbiota is
composed of thousands of species that are a mix of
potential pathogens and beneficial microbes. The host
uses a variety of innate and adaptive immune mechanisms
to limit microbial invasion and maintain a tolerogenic
environment that is still able to mount an appropriate
inflammatory response when needed.
The GI tract is the largest mucosal surface in the
human body and is lined with a single layer of columnar
intestinal epithelial cells (IECs), with an overlying glyco-
calyx, which form a physical barrier between the lumen
and the host. Antimicrobial peptides and proteins, such
as defensins, cathelicidins, C-type lectins and trefoil
peptides, are used to limit microbial invasion and main-
tain intestinal homeostasis. Specialized cell types, like M
cells and unique subsets of dendritic cells (DCs), play a
role in sampling lumenal antigens. Macrophages also
play a major role in the intestinal lamina propria (LP),
where they phagocytize and kill bacteria that have
escaped from the lumen, without the release of inflam-
matory mediators. While the adaptive immune system
plays an important function in establishing gut homeo-
stasis (Edelman and Kasper, 2008), the focus of this
review is the innate immune system in the GI tract. This
review will focus on innate effector mechanisms that the
host utilizes to control polymicrobial populations on GI
mucosal surfaces, beginning with the lumen and moving
inwards to the LP.
Lumenal defences and mucus layer
On the lumenal side of the GI mucosa, there are a variety
of antimicrobial proteins and peptides that target con-
served structures of microorganisms and inhibit their
growth (Fig. 1). The concentration, and therefore activity,
of these molecules is greatest at the mucosa–lumen inter-
face and they function largely to limit microbial attachment
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and invasion into the mucosa. One such antimicrobial
protein is lysozyme. Paneth cells in the small intestine
produce lysozyme and secrete it into the lumen where it
can target the lumenal microbiota. Lysozyme is very effec-
tive at inhibiting the growth of Gram-positive bacteria
because it is a glycosidase that hydrolyses the 1,4-b-
glycosidic linkages between N-acetylglucosamine and
N-acetylmuramic acid that make up peptidoglycan (Ganz,
2004). Gram-negative bacteria are not as easily targeted
by lysozyme due to the peptidoglycan being in the peri-
plasmic space. With its glycosidase activity, lysozyme
acts in a broad fashion throughout the small intestine to
target the cell wall of many bacteria.
Secretory phospholipase A2 (sPLA2) is another enzyme
that targets a conserved moiety in bacteria, through
hydrolysis of the phospholipid component of the bacterial
cell membrane. sPLA2 is produced by Paneth cells and
macrophages, so it is found ubiquitously throughout the
tissue layers of the GI tract (Vadas et al., 1993; Harwig
et al., 1995). This enzyme is basic, allowing it to penetrate
the bacterial cell wall to reach the bacterial membrane
where it hydrolyses the membrane phospholipids. In this
way, sPLA2 damages bacterial cell surfaces in a non-
specific manner.
Antibacterial proteins also play a critical role in
maintaining microbe–host homeostasis in the GI tract,
although the mechanisms of many of these proteins
remain unknown. C-type lectins, calcium-dependent
carbohydrate-binding proteins, are one group of anti-
bacterial proteins and include RegIIIg (and its correspond-
ing human protein, hepatocarcinoma-intestine-pancreas/
pancreatic-associated protein, HIP/PAP). They are ex-
pressed by Paneth cells and enterocytes in the small
intestine. RegIIIg targets Gram-positive bacteria specifi-
cally by binding to peptidoglycan to mediate bacterial
killing (Cash et al., 2006). The bactericidal mechanism of
RegIIIg is still not understood, and may be occurring via
enzymatic activity or through direct membrane disruption.
The mechanisms of the other members of the Reg family
of C-type lectins are also not understood, but many of
these Reg family members are expressed in GI tissues
(Dieckgraefe et al., 2002). The ubiquitous nature of these
Fig. 1. Mechanisms of the innate immune response in the gastrointestinal tract. This diagram shows the location of different cell types and
molecules that play a role in the innate immune response in the GI tract. The lumen of the GI tract is rich in microbes, but it also is dense with
various antimicrobial peptides, defensins and cathelicidins that all play a role in maintaining host–microbe homeostasis. Beneath the lumen is
the glycocalyx, which protects the intestinal epithelium. The epithelium forms a physical barrier to the lumen through the formation of tight
junctions between epithelial cells. M cells are also connected to intestinal epithelial cells with tight junctions, and M cells overlie the
subepithelial dome that is rich in dendritic cells. Underneath the SED is lymphoid tissue dense in B and T cells. In the lamina propria, many
classes of specialized dendritic cells and macrophages. One proposed mechanism of antigen recognition within the GI tract is that antigen
enters through the M cells to the dendritic cells in the SED. Dendritic cells are also capable of altering tight junctions to extend dendrites to
directly sample the lumenal contents. All of these cell types and specialized molecules play an important role in maintaining the strategic
alliance between the microbiota and the host.
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and other C-type lectins points towards a general anti-
bacterial defence mechanism in the GI tract.
Another class of broad spectrum antibacterial proteins
is the ribonuclease family. Angiogenin-4 (Ang-4) is a
member of this ribonuclease family, and like other
RNases, has the ability to hydrolyse RNA, but this enzy-
matic activity has not been directly linked to its bacteri-
cidal function. Ang-4 is broadly bactericidal, having
activity against Gram-positive and Gram-negative bacte-
ria through an unknown mechanism (Hooper et al., 2003).
Despite its broad bactericidal activity, Ang-4 is solely
expressed by Paneth cells, thus limiting its activity to the
small intestine. RNases undoubtedly play a role in main-
taining homeostasis in the GI tract where diverse popula-
tions of bacteria come into contact with the mucosa.
Defensins are the major family of membrane-disrupting
peptides and are highly expressed throughout the gut.
They are expressed by diverse cell types, including IECs,
neutrophils and macrophages. They are small peptides
ranging in size from 2 to 6 kDa and have conserved
cysteine residues that form disulfide bonds resulting in a
three-dimensional structure. Defensins are classified into
three groups, a, b and q, based on their disulfide bond
arrangements and the location of the cysteine residues
(Selsted and Ouellette, 2005). Regardless of their classi-
fication, the defensins are broadly antimicrobial, and
target both Gram-negative and Gram-positive bacteria.
Defensins have also been shown to be active against
some fungi, viruses, and even protozoa (Selsted and
Ouellette, 2005). The highly basic nature of defensins
permits electrostatic interactions with negatively charged
phospholipid groups found on bacterial membranes.
Defensins form pores to osmotically lyse the bacterium
when a critical concentration has been reached (Kagan
et al., 1990). The tissue-specific and heterogeneous
expression of the specific defensins along the mucosa
points towards a critical role in shaping the composition of
the microbial communities found at these different loca-
tions along the mucosa.
a-Defensins are expressed solely by Paneth cells
within the small intestine, most abundantly within the
distal ileum, and expression corresponds with maximum
bacterial exposure (Ouellette and Selsted, 1996). Murine
a-defensins (cryptdins), and mice have many cryptdin-
related sequence (CRS) peptides. These CRS peptides
all share four intramolecular disulfide bridges that form
covalent dimers through another intermolecular disulfide
bridge (Mukherjee et al., 2008). The CRS peptides can
form both heterodimers and homodimers and exhibit
broad spectrum antimicrobial activity against both Gram-
positive and Gram-negative bacteria. In humans, there
are two enteric a-defensins characterized so far, human
defensins 5 and 6 (HD-5 and HD-6). HD-5 localizes to
Paneth cells of the small intestine, but not of the stomach
or colon in healthy patients. During chronic inflammatory
bowel diseases the colonic mucosa is vulnerable to micro-
bial penetration, and HD-5 is expressed by Paneth cells
in the colonic epithelium. Another group of human
a-defensins are the neutrophil a-defensins, HNP 1–3,
which can be expressed by IECs, and not Paneth cells
during inflammatory bowel disease (Mukherjee et al.,
2008).
Unlike a-defensins, b-defensins are expressed in
enterocytes in the small and large intestine. In the intes-
tinal mucosa, multiple b-defensins are expressed, such as
hBD-1, hBD-2 and hBD-3. Unlike a-defensins that are
broadly bactericidal, each b-defensin has specific
bactericidal activity. hBD-1 and hBD-2 are active against
Gram-negative bacteria while hBD-3 is specific for Gram-
positive bacteria. In addition to their role as antimicrobial
peptides, both a- and b-defensins can be chemotactic for
T cells and DCs (Mukherjee et al., 2008). Through their
chemotactic ability, defensins play an important role in
innate immunity, but also modulate the adaptive immune
response within the GI tract.
Another class of membrane-disrupting antimicrobial
peptides found in the GI tract is the cathelicidins. These
peptides are expressed by neutrophils, epithelial cells in
the colon and other mucosal surfaces such as the lung
and urinary tract (Hase et al., 2002) and have bactericidal
activity similar to defensins. Cathelicidins bind to bacterial
membranes through electrostatic interactions to disrupt
the membrane of Gram-negative and Gram-positive bac-
teria as well as some fungi (Bals and Wilson, 2003). They
are cationic, a-helical peptides with a variable C-terminal
region and a conserved cathepsin L inhibitor (cathelin)-
like domain. LL-37 is one of these cathelicidins and has
been shown to have additional mechanisms aside from
bactericidial activity. LL-37 has been shown to induce Th1
cytokine secretion by DCs and to act chemotactically for
macrophages and T cells (Koczulla et al., 2003; Davidson
et al., 2004).
Another important lumenal effector protein is a product
of adaptive immunity. IgA, which is the predominant
immunoglobulin isotype secreted by plasma cells in the
LP, is a non-inflammatory immunoglobin found in high
concentrations in the lumen and mucosa as a dimer. The
polymeric immunoglobulin receptor (pIgR) is found on
enterocytes and attaches to the Fc of IgA, and remains
bound as secretory component (SC). SC prevents pro-
teolytic damage to secretory IgA (sIgA) in the harsh
environment of the lumen. SC also transfers antigen out
of the LP to the apical surface of the enterocytes using
pIgR (Kerr, 1990). sIgA plays a vital role in maintaining
immune homeostasis in the gut lumen.
The mucus layer forms the interface between the
lumenal contents and the epithelium, acting as a physical
barrier against the dense microbial population of the
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lumen. This protective barrier is composed of mucus gel,
bicarbonate and surfactant phospholipids, which results in
a neutral pH that protects the underlying epithelial cells.
Mucus gel is secreted by the gut epithelium and is a
combination of water and mucin glycoproteins. Trefoil
factor family (TFF) peptides are cosecreted with mucus.
TFFs are low-molecular-weight peptides that play a role in
assembly of mucins. TFF-2 stabilizes the mucus layer by
increasing the viscosity of gastric mucin as it is secreted
(Thim et al., 2002). Within the mucosal surface, the
glycocalyx is the most concentrated glycoprotein layer
that plays a role in regulating microparticle access to the
apical surface of IECs. The interaction between mucins
and TFFs results in a stable protective layer against acid,
bacteria, and other potentially damaging molecules.
The outermost extracellular layer (the film of mucus and
complex polysaccharides) on the lumenal side of the
epithelium also acts as a nutrient source for specific
(largely beneficial members of the microbiota). These
bacteria produce metabolites, such as short-chain fatty
acids (SCFA), bacteriocins and quorum sensing mole-
cules that can dampen innate inflammatory responses,
which aids in the alliance between the host and its
indigenous microbiota. These molecules are discussed
in more detail below in the ‘microbial control of gut
homeostasis’ section.
Epithelium
The innate immune system constantly samples the
diverse and numerous microbial products within the GI
tract, and to deal with this, there are specialized cell types
within the epithelium. This review will cover IECs, Goblet
cells, Paneth cells, mast cells and M cells. The IECs play
a dynamic role in GI immune homeostasis. IECs are
themselves a barrier, but they also secrete many antimi-
crobial peptides and proteins, as discussed earlier. The
presence of tight junctions (TJs) between IECs to prevent
the passage of molecules between cells is another impor-
tant characteristic and will be discussed below. They also
express a wide range of pattern recognition receptors
(PRRs) that recognize numerous commensal and
pathogenic bacterial factors, including lipopolysaccharide
(LPS), flagellin and unmethylated CpG-containing DNA
(Harris et al., 2006). While potentially pathogenic bacteria
tend to activate NF-kB through Toll-like receptors (TLRs)
and/or NOD-like receptors (NLRs), some non-pathogenic
bacteria can actively inhibit the NF-kB pathway (Harris
et al., 2006). In this way, bacteria can modulate the innate
immune system and the contribution of mutualistic
bacteria to this process is key to mucosal homeostasis.
Intestinal epithelial cells can also activate the adaptive
immune system through antigen presentation. IECs can
be induced to express MHC class II molecules, the invari-
ant chain and active cathepsins (intracellular proteases),
which points towards their role in antigen processing
and presentation to professional antigen presenting cells
(APCs) (Hershberg and Mayer, 2000). Because IECs lack
a costimulatory molecule, they are not able to prime naïve
T cells and may promote local T-cell tolerance to the
lumenal antigen.
One critical feature of the epithelium in the gut is the
presence of TJs between the IECs. All IECs express TJ
proteins and form TJ between each other, resulting in a
physical barrier between the LP and the lumen that is vital
for health. There are other intercellular junctions, but TJs
are the most apical and consist of the transmembrane
proteins claudin and junctional adhesion molecule and the
cytoplasmic plaque proteins, ZO-1, ZO-2, ZO-3, cingulin
and 7H6 (Qing-Hua and Qian, 2009). Butyrate, a bacterial
metabolite in the GI tract, can increase TJ protein expres-
sion to strengthen the barrier between the LP and bacteria
in the gut.
In the GI tract, specialized DCs play a pivotal role in
connecting the adaptive and innate immune response.
DCs in the gut are adept at acquiring antigens from the
lumen. One group of specialized DCs express TJ proteins
that allow the DCs to extend dendrites into the lumen
to directly sample the microbiota without compromising
mucosal barrier function. This process is dependent on
CX3C-chemokine receptor 1 (CX3CR1), and mice defi-
cient in CX3CR1 exhibit impaired lumenal sampling
(Rescigno et al., 2001). Many DCs localize within the
Peyer’s patches and mesenteric lymph nodes, but the
epithelium also plays a large role in DC localization and
regulation. One mechanism is through the IEC secretion of
thymic stromal lymphopoietin (TSLP), which is constitu-
tively expressed by epithelial cells within the GI tract and
other mucosal surfaces. During infection or tissue injury,
elevated levels of TSLP are secreted by IECs, which is a
potent activator of DCs (Rimoldi et al., 2005). Other factors
secreted by IECs that regulate DC function are TGF-b and
prostaglandin E2. TGFb produced by IECs inhibits the
NF-kB pathway, which limits DC expression of pro-
inflammatory cytokines.All of these studies point towards a
dynamic relationship in the gut between IECs and DCs that
links the adaptive and innate immune responses, lumenal
and tissue responses, and epithelial barrier functions.
Intraepithelial lymphocytes (IELs) in the GI tract play an
important role in regulating proliferation and differentiation
of IECs. IELs localize to the basolateral side of the gut
epithelium, but the mechanism of their interaction with
IECs is still unknown. The physical interaction between
IECs and IELs is aided by a hemophilic adhesion called
epithelial cell adhesion molecule that is expressed on
both cell types. In the small intestine, E-cadherin (epithe-
lial cell adhesion molecule) and occludin (TJ specific
plasma-membrane protein) are constitutively expressed
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by IELs, and may play a role in IEC barrier function
(Inagaki-Ohara et al., 2005). More studies are needed to
understand the barrier formed by IECs and IELs, because
in chronic inflammatory conditions in the GI tract, there is
a decrease in epithelial barrier function, and a correlated
increase in IELs (Nasrat et al., 2000).
gd T cells are a specialized group of innate T cells found
at epithelial and mucosal surfaces, and play a role in the
response to stress and inflammation. gd T cells can
influence immune homeostasis through secretion of
keratinocyte growth factor-1 (KGF-1), which induces pro-
liferation of epithelial cells in the GI tract, possibly reduc-
ing disease severity. gd T cells also recruit inflammatory
cells in response to tissue damage in the GI tract. In this
way, gd T cells play a vital role in maintaining tissue
integrity after injury. Mice lacking gd T cells show elevated
disease severity in models of inflammatory bowel
disease. The transfer of gd T cells to mice lacking gd T cells
is able to improve chemically induced colitis, supporting
the idea that gd T cells regulate intestinal inflammatory
responses. This was associated with an increase in
TGF-b and a decrease in IFN-g (Inagaki-Ohara et al.,
2004). Furthermore, gd T cells have been shown to
decrease IL-15 secretion by IECs and increase IL-8 and
IFN-g, all of which have been associated with restoring
epithelial homeostasis (Shibahara et al., 2005). Through
their role in maintaining tissue integrity and modulating
inflammatory responses, gd T cells act as a special type of
innate T cell that is important in gut homeostasis.
Mast cells reside near and within the epithelium of the
GI tract. Mast cells express FceRI on their surface and
become activated when antigen cross-links IgE bound to
these receptors. Upon activation, via surface IgE cross-
linking or other pathways, mast cell degranulation begins
rapidly. The molecules released by this degranulation are
a diverse group of biologically active proteins and chemi-
cal mediators. One such molecule is histamine, a vaso-
active amine, which increases blood flow and vessel
permeability. Other molecules released include prostag-
landins, leucotrienes and cytokines such as IL-4 and
IL-13. These mediators activate a variety of processes,
including attracting leucocytes, increasing vascular per-
meability and increasing mucin secretion. Intestinal mast
cells are typically rare in mice, but are recruited rapidly
during gastrointestinal infections caused by Trichinella
spiralis (Knight et al., 2008). Thus, mast cells are also a
critical bridge between adaptive and innate host defences
and play a key role in GI homeostasis.
Goblet cells are found throughout the epithelium of the
GI tract and produce the thick mucus layer that protects
the IECs. Goblet cells produce mucins and trefoil peptides
(discussed earlier) that form the glycocalyx that is found
throughout the entire GI tract. As discussed earlier, the
mucus layer forms a physical barrier between the lumen
and the GI epithelium. Goblet cells secrete elevated levels
of mucins upon exposure to bacteria or toxins in the
lumen (Kingdon et al., 1995). Goblet cells are also adept
at forming TJs with adjacent cells in the epithelium,
thereby maintaining the physical barrier between the host
and lumen.
Paneth cells are specialized epithelial cells found at the
base of small intestinal crypts. They produce several
important components in gut homeostasis, including
lysozyme, defensins and secretory phospholipase A2
(sPLA2) (as discussed previously). Studies in the murine
small intestine have found that Paneth cells secrete
predominantly cryptdins following exposure to Gram-
negative or Gram-positive bacteria (Ayabe et al., 2000).
However, fungi and protozoa did not stimulate Paneth cell
degranulation. Paneth cells play an important role in
responding to bacterial stimulation in the small intestine
through their release of antimicrobial peptides, especially
a-defensins.
Microfold cells (M cells) are specialized epithelial cells
that act as a bridge between innate and adaptive immu-
nity. M cells lack the microvilli of IECs, and instead have a
microfold appearance. Compared with IECs, M cell have
fewer lysosomes, more mitrochondria and lack the glyco-
calyx that is typical of the GI tract. Without a thick mucus
layer, M cells are more readily accessible to the micro-
biota in the lumen. Although the mechanism is not fully
understood, M cells make direct contact with the micro-
biota, and through transcytosis, deliver antigen to the
subepithelial dome where professional antigen presenting
cells are located. The M cells have modified apical and
basolateral surfaces that aid in antigen sampling. Studies
have shown that M cell transcytosis of bacteria and
viruses is receptor dependent (Tyrer et al., 2002). While
IECs express many PRRs on their surface, the receptors
utilized by M cells for lumenal sampling is unknown. One
difference in receptor expression between IECs and M
cells is the distribution of a5b1 integrin. IECs express
a5b1 integrin on their lateral and basolateral surfaces
while M cells only express a5b1integrin on the apical
surface (Tyrer et al., 2002). Studies inhibiting a5b1 inte-
grin on M cells resulted in inhibition of transcytosis. Other
receptors implicated in aiding M cell transcytosis are
TLR-4 and PAF receptor (Tyrer et al., 2006). Although
much remains to be understood about M cell function,
their role as a bridge between innate and adaptive immu-
nity may play a critical role in maintaining gut immune
homeostasis.
Lamina propria
Macrophages that differentiate in the intestinal LP have
distinct properties and function compared with macro-
phages at the site of microbial infections. Macrophages in
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the LP need to eliminate microbes while preserving gut
homeostasis, resulting in a specialized subset that is
highly phagocytic but have reduced pro-inflammatory
cytokine production and lessened costimulatory activities.
Some distinct properties of these LP macrophages are
diminished cell surface expression of CD40, CD80 and
CD86, while maintaining phagocytic and bactericidal
activity (Smythies et al., 2005). LP macrophages are also
deficient in some innate immune response receptors,
such as TLR-4. Due to this, intestinal macrophages do not
respond to LPS or many other PAMPs. Other alterations
in receptor expression in LP macrophages is the absence
of the Fc receptor for IgA and for IgG, complement recep-
tors CR3 and CR4, and integrin a2b1. LP macrophages
are also less responsive to pro-inflammatory cytokines
resulting in a more tolerant GI environment. The lack
of several receptors that typically induce the adaptive
immune response allows LP macrophages to eliminate
microbes without cytokine secretion and the activation of
immune cells.
However, the leucocytes in the LP are also able to
respond to microbes by developing strong inflammatory
and adaptive responses. In models of intestinal inflamma-
tion, LP macrophages have an inflammatory phenotype
and function. When inflammation is present in the
mucosa, LP macrophages express CD40, CD80 and
CD86 at appropriate levels, unlike during steady state in
the gut (Rugtveit et al., 1997). LP macrophages have also
been found to express TLR-2, TLR-4, CD14 and CD89
during inflammatory conditions (Rogler et al., 1997). In
addition to inflammatory LP macrophages, neutrophils
can also play a role in inflammation of the LP. The LP is
also the predominant site of T- and B- cells in the GI tract,
including specialized lymphoid tissue underlying the M
cells and subepithelial dome that is rich in B- and T-cells
(Peyer’s Patches). These cells are localized to detect
infiltrating bacteria and mount the appropriate adaptive
immune response. In the GI tract, each organ has char-
acteristic lymphocyte populations and characteristics that
directly affect the adaptive immune function of the organ.
Microbial control of gut homeostasis
The microbiota has a significant impact on the innate
defences of the GI tract, so it is not a surprise that anti-
biotics are beginning to be implicated in alterations of gut
innate defences. Because antibiotics disrupt the bacterial
community, this interrupts the strategic alliance between
the microbiota and the host. Recently, an association
between antibiotic use and an increase in colonization by
pathogenic bacteria has been found. Brandl et al. (2008)
found that eliminating commensal bacteria with antibiot-
ics, led to an outgrowth of enterococci. Notably, antibiotic
use downregulated the intestinal expression of RegIIIg,
which plays a role in Gram-positive bacterial killing. In this
study, the use of a combination of metronidazole, neomy-
cin and vancomycin resulted in a decrease in commensal
bacteria and compromised part of the innate immune
defence in the GI tract. However, different broad-
spectrum antibiotic regimens also showed similar results.
Bacterial metabolites play a large role in influencing the
innate defence system in the GI tract. One group of these
metabolites is the bacteriocins, of which there are several
classes (more may still be discovered) (Galvez et al.,
2007). Almost all bacteria produce one or more bacterio-
cins (Riley, 1998) and these small antimicrobial peptides
have varying spectra of activity against other bacteria.
Thus, similar to antimicrobials produced by the host, bac-
teriocins can function in innate defence against potentially
pathogenic bacteria in the gut. The real importance of
bacteriocins in maintaining a balance between the micro-
biota and the host remains to be determined.
Quorum sensing molecules are another bacterial
metabolite that can affect the innate defences in the gut.
Bacteria in the GI tract use auto-inducers as a cell to cell
signalling mechanism to sense bacterial concentration in
the local environment (Reading and Sperandio, 2006).
Gram-negative bacteria typically use acyl homoserine lac-
tones as auto-inducers, while Gram-positive bacteria tend
to use auto-inducing polypeptides as their auto-inducers.
Bacteria rely on these chemicals to detect, and accord-
ingly alter gene expression based on the density of the
auto-inducer. It has been suggested that pathogenic bac-
teria may rely upon quorum sensing to aid in their viru-
lence, by promoting the expression of virulence factors
when the bacteria has reached a significant concentration
in the gut. However, some studies have found that
quorum sensing can aid in bacterial to host communica-
tion. The auto-inducer for Pseudomonas aeruginosa can
downregulate TNFa and IL-12 production in leucocytes
and upregulated IFNg expression (Telford et al., 1998).
Given that bacteria can alter the host innate immune
response, the role of quorum sensing for commensal
bacteria needs to be further studied to understand that
function of bacterial–host cross-talk in maintaining
homeostasis within the gut (Hsiao et al., 2008).
Short-chain fatty acids, such as butyric acid/butyrate,
are by-products of anaerobic fermentation by the normal
members of the microbiota and are found in high levels in
the GI tract. Butyrate possesses potent anti-inflammatory
activity in a variety of in vitro culture systems (Bohmig
et al., 1997; Andoh et al., 1999; Säemann et al., 2000;
2002; Cavaglieri et al., 2003). In addition, butyrate is
critical for intestinal epithelial integrity and health, which
reduces GI ‘leak’ of antigens that could stimulate immune
responses (Nagler-Anderson et al., 2001; Bach Knudsen
et al., 2003). Increased mucosal permeability is a very
early change in colitis induced by DSS, is accompanied
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by decreased cell survival, and precedes detectable
changes in histology. Butyrate has been used to treat
colitis and can reverse the increased mucosal permeabil-
ity in this disease (Okamoto et al., 2000; Venkatraman
et al., 2000). Butyrate can also prevent LPS-induced
maturation of bone marrow-derived DC in mice and
monocyte-derived DC in humans, including preventing
homotypic DC clustering (aggregations associated with
increased functional and phenotypic maturation of DCs),
inhibiting IL-12, decreasing costimulatory molecule
expression and blocking NF-kB translocation (Millard
et al., 2002; Säemann et al., 2002). While Lactobacilli are
poor producers of butyrate, they can produce ample
quantities of lactic acid, which can be rapidly converted to
butyrate by other members of the normal microbiota, such
as Clostridiales. (Tsukahara et al., 2002; Wullt et al.,
2007). Within the gut, a variety of polysaccharides can be
utilized by butyrate-producing firmicutes and some
species have high metabolic versatility (Louis and Flint,
2009). The ability, of some bacteria in the gut, to utilize
different polysaccharide sources to produce butyrate
implies that these bacteria play an important role in both
dietary components and immunomodulatory effects.
Summary/conclusions
The microbiota and innate immune system in the GI tract
maintain a strategic alliance that allows for nutrition
absorption while restricting pathogen access to the host.
To cope with the constant exposure to a diverse microbial
community, the GI tract, through the actions of a number
of specialized cells in the epithelium and LP, has layers of
humoral, physical and cellular defences that limit attach-
ment, invasion and dissemination of the indigenous
microbiota. However, the role of the microbiota in this
dynamic balance is vital. Pathogens are further kept in
check through the secretion of bacteriocins, quorum
sensing molecule production to alter gene expression and
SCFA production. All of these bacterial metabolites aid in
the control of potential pathogens. The relationship
between the indigenous microbiota and the host immune
system emphasizes the need for a clearer understanding
of the bacterial–host partnership in maintaining GI tract
homeostasis.
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